Product Code: SR112023A5741
Market Overview:
The global bone growth stimulator market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.05% during 2023-2028.
A bone growth stimulator is a medical device used to boost the healing process of bones after a spinal fusion surgery or fracture. It relies on ultrasonic or pulsed electromagnetic waves to assist the body in tissue repairing and cell creation while increasing bone density. It helps treat nonunion fractures that occur due to the lack of stability, blood flow, and infections, particularly after surgery. In addition, it offers several advantages, including a painless healing process, low complication rates compared to other invasive methods, and increasing patient compliance. As a result, it finds extensive applications in hospitals, clinics, and home care centers across the globe.
Bone Growth Stimulator Market Trends:
At present, there is a rise in the demand for minimally invasive (MI) procedures due to fewer operative complications, shorter hospitalization, less pain, reduced postoperative care, quicker recovery, smaller and more cosmetic incisions, and lower risk of infection. This, along with the growing geriatric population around the world, represents one of the key factors driving the market. Moreover, the increasing sports-related orthopedic injuries among individuals due to poor training practices, improper equipment, insufficient warm-up and stretching, and lack of conditioning are propelling the growth of the market. In addition, governments of several countries are extensively investing in medical equipment and devices. This, coupled with the burgeoning healthcare industry across the globe, is offering lucrative growth opportunities to industry players. Besides this, the growing awareness among physicians, surgeons, and patients about the benefits of bone growth stimulators for spinal fusion and bone healing is positively influencing the market. Additionally, the rising prevalence of arthritis, diabetes, and other medical conditions, such as obesity, vascular disease, and renal disorders, is strengthening the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global bone growth stimulator market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.
Breakup by Product:
Bone Growth Stimulation Devices
Bone Morphogenetic Proteins
Platelet-Rich Plasma
Breakup by Application:
Spinal Fusion Surgeries
Delayed Union and Nonunion Bone Fractures
Oral and Maxillofacial Surgeries
Others
Breakup by End User:
Hospitals and Clinics
Home Care
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc., DJO Global Inc., Elizur Corporation, IGEA S.p.A., Isto Biologics, Ito Co. Ltd., Medical Device Business Services Inc. (Johnson & Johnson), Medtronic Plc, Orthofix Medical Inc., Ossatec Benelux B.V., Stryker Corporation, Terumo Bct Inc. (Terumo Corporation) and Zimmer Biomet
Key Questions Answered in This Report:
- How has the global bone growth stimulator market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global bone growth stimulator market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global bone growth stimulator market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Bone Growth Stimulator Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Bone Growth Stimulation Devices
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Bone Morphogenetic Proteins
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Platelet-Rich Plasma
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Application
- 7.1 Spinal Fusion Surgeries
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Delayed Union and Nonunion Bone Fractures
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Oral and Maxillofacial Surgeries
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals and Clinics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Home Care
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Arthrex Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 SWOT Analysis
- 14.3.2 DJO Global Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Elizur Corporation
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 IGEA S.p.A.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Isto Biologics
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Ito Co. Ltd.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Medical Device Business Services Inc. (Johnson & Johnson)
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Medtronic Plc
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Orthofix Medical Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Ossatec Benelux B.V.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Stryker Corporation
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.12 Terumo Bct Inc. (Terumo Corporation)
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 SWOT Analysis
- 14.3.13 Zimmer Biomet
- 14.3.13.1 Company Overview
- 14.3.13.2 Product Portfolio
- 14.3.13.3 Financials
- 14.3.13.4 SWOT Analysis